Event-free and overall survival of 242 patients with T-cell lymphoma (patients with ALK-positive ALCL are excluded); Cox model adjusted for IPI factors showing the relative risk for failure relating to histological subtypes
| . | EFS . | OS . | P . | |||
|---|---|---|---|---|---|---|
| RR . | 95% CI . | P . | RR . | 95% CI . | ||
| PTCLU vs ALK-negative ALCL | 1.1 | (0.7; 1.6) | .720 | 1.1 | (0.7; 1.7) | .768 |
| AITL vs ALK-negative ALCL | 0.6 | (0.3; 1.0) | .046 | 0.5 | (0.2; 1.0) | .037 |
| Other* vs ALK-negative ALCL | 1.7 | (1.0; 2.7) | .038 | 2.0 | (1.2; 3.5) | .009 |
| . | EFS . | OS . | P . | |||
|---|---|---|---|---|---|---|
| RR . | 95% CI . | P . | RR . | 95% CI . | ||
| PTCLU vs ALK-negative ALCL | 1.1 | (0.7; 1.6) | .720 | 1.1 | (0.7; 1.7) | .768 |
| AITL vs ALK-negative ALCL | 0.6 | (0.3; 1.0) | .046 | 0.5 | (0.2; 1.0) | .037 |
| Other* vs ALK-negative ALCL | 1.7 | (1.0; 2.7) | .038 | 2.0 | (1.2; 3.5) | .009 |
Patients not belonging to the 4 major T-NHL subtypes